Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0471

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 80425-0471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine HCl Er 75mg #30 (Venlafaxine HCl Er 75mg 80425 0471 01)

Packaging label for Venlafaxine Hydrochloride ER 75 mg capsule by Advanced Rx of Tennessee, LLC. The label includes storage instructions (20°-25°C), prescription use indication (Rx Only), a lot number and expiration date area, and barcode information. It also compares to Effexor XR and includes a retail pharmacy serial number.*

FDA Label Image

Venlafaxine HCl Er 75mg #60 (Venlafaxine HCl Er 75mg 80425 0471 02)

Packaging label for Venlafaxine Hydrochloride Extended Release Capsules, 75 mg, from Advanced Rx of Tennessee, LLC. The label includes storage instructions at 20-25°C, cautions against federal law prohibiting transfer, and displays NDC 80425-0471-02 with comparison to Effexor XR. The package count is #60 capsules.*

FDA Label Image

Venlafaxine HCl Er 75mg #90 (Venlafaxine HCl Er 75mg 80425 0471 03)

Venlafaxine Hydrochloride 75 mg extended-release capsule packaging label from Advanced Rx of Tennessee, LLC. The label includes storage instructions, lot and expiration date fields, and references a comparison to Effexor XR. The package size is indicated as 90 capsules. The label also shows barcodes and dispensing pharmacy information.*

FDA Label Image

Figure-1 (Figure 1)

A scatter plot showing the fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax, AUC, ODV) for venlafaxine in various special populations including hepatic cirrhosis, mild/moderate impairment, renal impairment, hemodialysis, CYP2D6 polymorphism, age over 60, and gender differences. The x-axis represents change relative to reference values with a vertical line at 1.*

FDA Label Image

Figure-2 (Figure 2)

A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, ODV) of venlafaxine in presence of various interacting drugs including Ethanol, Diazepam, Cimetidine, Ketoconazole (in CYP2D6 EM's and PM's), Indinavir, Metoprolol, Imipramine, and Lithium. The x-axis represents change relative to the reference value from 0 to 3.*

FDA Label Image

Figure-3 (Figure 3)

A scatter plot chart showing fold changes and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes when interacting with different drugs, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents change relative to the reference value, ranging from 0 to 3, with data points clustered around a fold change of 1.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Chemical structure of Venlafaxine Hydrochloride, showing its molecular components including a chiral center marked in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.